KPV Protocol, Dosing & Timeline | Peptide Dose Wizard

KPV Overview

Mechanism of Action

KPV (Lysine-Proline-Valine) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH). It exerts potent anti-inflammatory effects by inhibiting NF-κB activation and reducing pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) without interacting with melanocortin receptors. KPV also has direct antimicrobial activity against bacteria including S. aureus and C. albicans.

Half-Life

Short plasma half-life; tissue effects persist several hours

Timing

No specific timing required

Injection Site

Subcutaneous, abdomen

Food

No restrictions

Common Stacks

BPC-157 — Gut healing synergy
GHK-Cu — Tissue repair + anti-inflammatory (the KLOW blend)
LL-37 — Antimicrobial + anti-inflammatory combination

KPV Dosing Protocol

Standard Protocol

4–8 weeks

200–500 mcg daily

Subcutaneous for systemic inflammation; some use oral for gut-targeted effects.

Gut Protocol

4–6 weeks

200–500 mcg daily

Often combined with BPC-157 for comprehensive gut healing.

KPV Expected Timeline

Week 1–2

Reduced systemic inflammation; improved GI comfort

Week 2–4

Noticeable improvement in inflammatory symptoms

Week 4–8

Sustained anti-inflammatory benefit; improved mucosal healing

KPV Side Effects

Very well tolerated

Minimal reported side effects

KPV Research Studies

KPV, an α-melanocyte-stimulating hormone-derived peptide, exerts anti-inflammatory properties

Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. — Proc Natl Acad Sci USA (2008)

Demonstrated KPV inhibited NF-κB activation and reduced inflammatory cytokines in colonic epithelial cells, showing therapeutic potential for inflammatory bowel disease.

PubMed: 18824688

The tripeptide KPV attenuates intestinal inflammation

Kannengiesser K, Maaser C, Heidemann J, et al. — J Cell Mol Med (2008)

Showed KPV significantly reduced intestinal inflammation in murine colitis models by modulating inflammatory signaling pathways.

PubMed: 18624770

KPV FAQ

How is KPV different from α-MSH?

KPV retains the anti-inflammatory and antimicrobial properties of α-MSH but does NOT activate melanocortin receptors. This means it provides immune benefits without the tanning, appetite, or sexual side effects associated with full-length melanocortin peptides like Melanotan II.

Is KPV in the KLOW blend?

Yes. The KLOW blend combines KPV with GHK-Cu, BPC-157, and TB-500 for a comprehensive anti-inflammatory, antimicrobial, and tissue-repair formula. KPV can also be used as a standalone peptide for focused anti-inflammatory support.